0000866291false00008662912026-01-292026-01-29

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 29, 2026

 

 

Allegro MicroSystems, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39675

46-2405937

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

955 Perimeter Road

 

Manchester, New Hampshire

 

03103

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (603) 626-2300

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, par value $0.01 per share

 

ALGM

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02 Results of Operations and Financial Condition.

On January 29, 2026, Allegro MicroSystems, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended December 26, 2025. The full text of the press release issued is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

Exhibit 99.1

Press Release issued by Allegro MicroSystems, Inc. on January 29, 2026

Exhibit 104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ALLEGRO MICROSYSTEMS, INC.

Date: January 29, 2026

By:

  /s/ Derek P. D’Antilio

 Derek P. D’Antilio

 Executive Vice President, Chief Financial Officer and Treasurer

 


Exhibit 99.1

Allegro MicroSystems Reports Third Quarter 2026 Results

Sales Increased 29% Year-Over-Year and 7% Quarter-Over-Quarter to $229 Million

 

Manchester, NH, January 29, 2026 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced financial results for its third quarter ended December 26, 2025.

 

“We delivered strong third quarter results, with sales of $229 million exceeding the high end of our guidance range. Additionally,
non-GAAP EPS more than doubled year-over-year to $0.15. This performance was driven by broad strength in Automotive sales, which grew 28% year-over-year, including a 46% increase in e-Mobility. Our Industrial sales also saw robust growth, increasing 31% year-over-year, led by another record quarter in Data Center,” said Mike Doogue, President and CEO of Allegro. “We continued to see growing bookings and backlog, and a significant annual increase in year-to-date design wins. We are excited to provide a deeper look into our longer-term strategy, growth drivers and target model at our upcoming Analyst Day.”

 

Third Quarter Financial Highlights:

In thousands, except per share data

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

 

(Unaudited)

 

Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Automotive

 

$

164,543

 

 

$

155,845

 

 

$

128,637

 

 

$

464,652

 

 

$

395,711

 

Industrial and Other

 

 

64,667

 

 

 

58,449

 

 

 

49,235

 

 

 

182,257

 

 

 

136,471

 

Total net sales

 

$

229,210

 

 

$

214,294

 

 

$

177,872

 

 

$

646,909

 

 

$

532,182

 

GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

46.7

%

 

 

46.3

%

 

 

45.7

%

 

 

46.0

%

 

 

45.4

%

Operating margin %

 

 

4.2

%

 

 

2.9

%

 

 

%

 

 

2.0

%

 

 

(1.2

)%

Diluted EPS

 

$

0.04

 

 

$

0.03

 

 

$

(0.04

)

 

$

0.01

 

 

$

(0.31

)

Non-GAAP Financial Measures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross margin %

 

 

49.9

%

 

 

49.6

%

 

 

49.1

%

 

 

49.2

%

 

 

48.9

%

Operating margin %

 

 

15.4

%

 

 

13.9

%

 

 

10.8

%

 

 

13.6

%

 

 

9.6

%

Diluted EPS

 

$

0.15

 

 

$

0.13

 

 

$

0.07

 

 

$

0.37

 

 

$

0.18

 

Business Outlook

For the fourth quarter of fiscal year 2026 ending March 27, 2026, the Company expects total net sales to be in the range of
$230 million to $240 million. At the midpoint of this range, it implies growth in net sales of 22% year-over-year.

The Company also estimates the following results on a non-GAAP basis:

Gross Margin is expected to be between 49% and 51%,
Operating expenses are expected to increase by approximately 3% sequentially to $81 million, largely due to annual payroll tax resets,
Interest expense is expected to be approximately $5 million, and
Diluted Earnings per Share is expected to be between $0.14 and $0.18.

 

“Earlier this month, we repriced our term loan down another 25 basis points to SOFR plus 175 basis points resulting in an additional $700,000 reduction in annualized interest expense. This repricing reflects our lenders’ confidence in our business model and financial discipline,” said Derek D’Antilio, EVP and CFO of Allegro.

 

Allegro has not provided a reconciliation of its fourth fiscal quarter outlook for non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Interest Expense, and non-GAAP Diluted Earnings per Share because estimates of all of the reconciling items cannot be provided without unreasonable efforts. It is difficult to reasonably provide a forward-looking estimate between such forward-looking non-GAAP measures and the comparable forward-looking U.S. generally accepted accounting principles (“GAAP”) measures. Certain factors that are materially significant to Allegro’s ability to estimate these items are out of its control and/or cannot be reasonably predicted.


Earnings Webcast

A webcast will be held on Thursday, January 29, 2026 at 8:30 a.m., Eastern Time. Michael C. Doogue, President and Chief Executive Officer, and Derek P. D’Antilio, Executive Vice President and Chief Financial Officer, will discuss Allegro’s business and financial results.

The webcast will be available on the Investor Relations section of the Company’s website at investors.allegromicro.com. A recording of the webcast will be posted in the same location shortly after the call concludes and will be available for at least 90 days.

About Allegro MicroSystems

Allegro MicroSystems, Inc. is leveraging more than three decades of expertise in magnetic sensing and power ICs, to propel automotive, clean energy and industrial automation forward with solutions that enhance efficiency, performance and sustainability. Allegro’s commitment to quality drives transformation across industries, reinforcing our status as a pioneer in “automotive grade” technology and a partner in our customers’ success. For additional information, please visit https://www.allegromicro.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, contained in this press release including statements regarding our future results of operations and financial position, business strategy, prospective products and the plans and objectives of management for future operations, including, among others, statements regarding the liquidity, growth and profitability strategies and factors affecting our business are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

Without limiting the foregoing, in some cases, you can identify forward-looking statements by terms such as “aim,” “may,” “will,” “should,” “expect,” “exploring,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “would,” “contemplate,” “believe,” “estimate,” “predict,” “potential,” “seek,” or “continue” or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. No forward-looking statement is a guarantee of future results, performance or achievements, and one should avoid placing undue reliance on such statements.

Forward-looking statements are based on our management’s current expectations, beliefs and assumptions and on information currently available to us. Such beliefs and assumptions may or may not prove to be correct. Additionally, such forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the year ended March 28, 2025, as any such factors may be updated from time to time in our Quarterly Reports on Form 10-Q and our other filings with the Securities and Exchange Commission (the “SEC”). These risks and uncertainties include, but are not limited to: downturns or volatility in general economic conditions; our ability to compete effectively, expand our market share and increase our net sales and profitability; our reliance on a limited number of third-party semiconductor wafer fabrication facilities and suppliers of other materials; any failure to adjust purchase commitments and inventory management based on changing market conditions or customer demand; shifts in our product mix, customer mix or channel mix, which could negatively impact our gross margin; the cyclical nature of the semiconductor industry, including the analog segment in which we compete; any downturn or disruption in the automotive market or industry; our ability to successfully integrate the acquisition of other companies or technologies and products into our business; our ability to compensate for decreases in average selling prices of our products and increases in input costs; our ability to manage any sustained yield problems or other delays at our third-party wafer fabrication facilities or in the final assembly and test of our products; our ability to accurately predict our quarterly net sales and operating results and meet the expectations of investors; our dependence on manufacturing operations in the Philippines; our reliance on distributors to generate sales; events beyond our control impacting us, our key suppliers or our manufacturing partners; our ability to develop new product features or new products in a timely and cost-effective manner; our dependence on growth in the end markets that use our products and the impact that slowdowns in such growth could have on our financial results; the loss of one or more significant customers; our ability to identify, enter and expand in new markets, and to generate returns on such investments; uncertainties related to the design win process and our ability to recover design and development expenses and to generate timely or sufficient net sales or margins; changes in government trade policies, including the imposition of export restrictions and tariffs; our exposures to warranty claims, product liability claims and product recalls; our dependence on international customers and operations; the availability of rebates, tax credits and other financial incentives on end-user demands for certain products; risks, liabilities, costs and obligations related to governmental regulations and other legal obligations, including export/trade control, privacy, data protection, information security, cybersecurity, consumer protection, environmental and occupational health and safety, antitrust, anti-corruption and anti-bribery, product safety, environmental protection, employment matters and tax; the risk of unsolicited acquisition proposals; the volatility of currency exchange rates; our ability to raise capital to support our growth strategy; our indebtedness may limit our flexibility to operate our business; our ability to retain key and highly skilled personnel; the impact of restructuring activities on our business and operating


results; our ability to protect our proprietary technology and inventions through patents or trade secrets; our ability to commercialize our products without infringing third-party intellectual property rights; disruptions or breaches of our information technology systems or confidential information or those of our third-party service providers; any failure to maintain effective internal control over financial reporting; changes in tax rates or the adoption of new tax legislation; the negative impacts of sustained inflation on our business; the risks presented by climate change; the risks related to ESG matters; and other events beyond our control. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties.

You should read this press release and the documents that we reference completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. All forward-looking statements speak only as of the date of this press release, and except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements, whether as a result of any new information, future events, changed circumstances or otherwise.

This press release includes certain non-GAAP financial measures as defined by the SEC rules. These non-GAAP financial measures are provided in addition to, and not as a substitute for or superior to measures of, financial performance prepared in accordance with GAAP. There are a number of limitations related to the use of these non-GAAP financial measures versus their most directly comparable GAAP equivalents. For example, other companies may calculate non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of the presented non-GAAP financial measures as tools for comparison.

This press release may not be reproduced, forwarded to any person or published, in whole or in part.


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share amounts)

(Unaudited)

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

Net sales

 

$

229,210

 

 

$

177,872

 

 

$

646,909

 

 

$

532,182

 

Cost of goods sold

 

 

122,109

 

 

 

96,657

 

 

 

349,214

 

 

 

290,534

 

Gross profit

 

 

107,101

 

 

 

81,215

 

 

 

297,695

 

 

 

241,648

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

52,878

 

 

 

43,317

 

 

 

150,269

 

 

 

132,031

 

Selling, general and administrative

 

 

44,649

 

 

 

37,939

 

 

 

134,349

 

 

 

116,221

 

Total operating expenses

 

 

97,527

 

 

 

81,256

 

 

 

284,618

 

 

 

248,252

 

Operating income (loss)

 

 

9,574

 

 

 

(41

)

 

 

13,077

 

 

 

(6,604

)

Interest and other expense

 

 

(9,080

)

 

 

(7,561

)

 

 

(25,291

)

 

 

(25,902

)

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

(34,752

)

Income (loss) before income taxes

 

 

494

 

 

 

(7,602

)

 

 

(12,214

)

 

 

(67,258

)

Income tax benefit

 

 

(7,868

)

 

 

(803

)

 

 

(13,997

)

 

 

(9,233

)

Net income (loss)

 

 

8,362

 

 

 

(6,799

)

 

 

1,783

 

 

 

(58,025

)

Net income attributable to non-controlling interests

 

 

63

 

 

 

61

 

 

 

192

 

 

 

185

 

Net income (loss) attributable to Allegro MicroSystems, Inc.

 

$

8,299

 

 

$

(6,860

)

 

$

1,591

 

 

$

(58,210

)

Net income (loss) per common share attributable to Allegro MicroSystems, Inc.:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.04

 

 

$

(0.04

)

 

$

0.01

 

 

$

(0.31

)

Diluted

 

$

0.04

 

 

$

(0.04

)

 

$

0.01

 

 

$

(0.31

)

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

185,172,199

 

 

 

184,011,189

 

 

 

184,944,427

 

 

 

188,886,583

 

Diluted

 

 

186,208,258

 

 

 

184,011,189

 

 

 

185,998,601

 

 

 

188,886,583

 

 

Supplemental Schedule of Total Net Sales

The following table summarizes total net sales by market within the Company’s unaudited condensed consolidated statements of operations:

 

Three-Month Period Ended

 

 

Change

 

 

Nine-Month Period Ended

 

 

Change

 

 

December 26, 2025

 

 

December 27, 2024

 

 

Amount

 

 

%

 

 

December 26, 2025

 

 

December 27, 2024

 

 

Amount

 

 

%

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

Automotive

 

$

164,543

 

 

$

128,637

 

 

$

35,906

 

 

 

28

%

 

$

464,652

 

 

$

395,711

 

 

$

68,941

 

 

 

17

%

Industrial and Other

 

 

64,667

 

 

 

49,235

 

 

 

15,432

 

 

 

31

%

 

 

182,257

 

 

 

136,471

 

 

 

45,786

 

 

 

34

%

Total net sales

 

$

229,210

 

 

$

177,872

 

 

$

51,338

 

 

 

29

%

 

$

646,909

 

 

$

532,182

 

 

$

114,727

 

 

 

22

%

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

December 26,

 

 

March 28,

 

 

2025
(Unaudited)

 

 

2025

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

155,187

 

 

$

121,334

 

Restricted cash

 

 

8,212

 

 

 

9,773

 

Trade accounts receivable, net

 

 

99,651

 

 

 

84,598

 

Inventories

 

 

178,195

 

 

 

183,914

 

Prepaid income taxes

 

 

14,567

 

 

 

36,662

 

Prepaid expenses and other current assets

 

 

47,672

 

 

 

30,247

 

Assets held for sale

 

 

11,928

 

 

 

16,508

 

Total current assets

 

 

515,412

 

 

 

483,036

 

Property, plant and equipment, net

 

 

300,861

 

 

 

302,919

 

Deferred income tax assets

 

 

76,703

 

 

 

68,528

 

Goodwill

 

 

203,492

 

 

 

202,475

 

Intangible assets, net

 

 

244,838

 

 

 

262,115

 

Equity investment in related party

 

 

24,978

 

 

 

31,695

 

Other assets

 

 

56,427

 

 

 

70,193

 

Total assets

 

$

1,422,711

 

 

$

1,420,961

 

Liabilities, Non-Controlling Interest and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Trade accounts payable

 

$

52,558

 

 

$

38,733

 

Amounts due to related party, net

 

 

4,749

 

 

 

6,535

 

Accrued expenses and other current liabilities

 

 

82,282

 

 

 

65,570

 

Current portion of long-term debt

 

 

1,556

 

 

 

1,423

 

Total current liabilities

 

 

141,145

 

 

 

112,261

 

Long-term debt

 

 

286,158

 

 

 

344,703

 

Other long-term liabilities

 

 

30,994

 

 

 

32,897

 

Total liabilities

 

 

458,297

 

 

 

489,861

 

Commitments and contingencies

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

1,852

 

 

 

1,843

 

Additional paid-in capital

 

 

1,040,799

 

 

 

1,012,055

 

Accumulated deficit

 

 

(52,000

)

 

 

(53,591

)

Accumulated other comprehensive loss

 

 

(27,919

)

 

 

(30,752

)

Equity attributable to Allegro MicroSystems, Inc.

 

 

962,732

 

 

 

929,555

 

Non-controlling interest

 

 

1,682

 

 

 

1,545

 

Total stockholders’ equity

 

 

964,414

 

 

 

931,100

 

Total liabilities, non-controlling interest and stockholders’ equity

 

$

1,422,711

 

 

$

1,420,961

 

 


ALLEGRO MICROSYSTEMS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

8,362

 

 

$

(6,799

)

 

$

1,783

 

 

$

(58,025

)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

17,001

 

 

 

16,123

 

 

 

49,828

 

 

 

48,578

 

Amortization of deferred financing costs

 

 

298

 

 

 

694

 

 

 

1,948

 

 

 

1,781

 

Deferred income taxes

 

 

(3,814

)

 

 

(3,751

)

 

 

(7,985

)

 

 

(11,546

)

Stock-based compensation

 

 

12,820

 

 

 

10,588

 

 

 

37,263

 

 

 

32,251

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

34,752

 

Provisions for inventory and expected credit losses

 

 

3,011

 

 

 

3,031

 

 

 

7,554

 

 

 

7,519

 

Other non-cash reconciling items

 

 

146

 

 

 

68

 

 

 

305

 

 

 

6,645

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

6,119

 

 

 

(7,061

)

 

 

(15,604

)

 

 

34,356

 

Inventories

 

 

(10,526

)

 

 

(19,243

)

 

 

(1,273

)

 

 

(38,074

)

Prepaid expenses and other assets

 

 

(8,928

)

 

 

14,407

 

 

 

17,699

 

 

 

(1,401

)

Trade accounts payable

 

 

9,500

 

 

 

(8,203

)

 

 

13,681

 

 

 

5,467

 

Due to and from related parties

 

 

1,486

 

 

 

(3,568

)

 

 

(1,786

)

 

 

564

 

Other changes in operating assets and liabilities, net

 

 

9,900

 

 

 

(4,469

)

 

 

23,942

 

 

 

(21,307

)

Net cash provided by (used in) operating activities

 

 

45,375

 

 

 

(8,183

)

 

 

127,355

 

 

 

41,560

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(4,116

)

 

 

(13,615

)

 

 

(21,160

)

 

 

(34,564

)

Acquisition of business, net of cash acquired

 

 

 

 

 

319

 

 

 

 

 

 

319

 

Net cash used in investing activities

 

 

(4,116

)

 

 

(13,296

)

 

 

(21,160

)

 

 

(34,245

)

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Net proceeds from Refinanced Term Loan Facility

 

 

 

 

 

 

 

 

 

 

 

193,483

 

Repayment of term loan

 

 

 

 

 

(25,000

)

 

 

(60,000

)

 

 

(75,000

)

Finance lease payments

 

 

(314

)

 

 

(318

)

 

 

(852

)

 

 

(703

)

Receipts on related party notes receivable

 

 

 

 

 

 

 

 

 

 

 

1,875

 

Payments for intangible assets

 

 

(3,000

)

 

 

 

 

 

(4,000

)

 

 

 

Payments for taxes related to net share settlement of equity awards

 

 

(1,005

)

 

 

(483

)

 

 

(10,354

)

 

 

(12,780

)

Proceeds from issuance of common stock under employee stock purchase plan

 

 

 

 

 

 

 

 

1,910

 

 

 

1,987

 

Repurchases of common stock

 

 

 

 

 

(116

)

 

 

 

 

 

(853,921

)

Payments for taxes related to repurchase of common stock

 

 

 

 

 

 

 

 

(1,713

)

 

 

 

Net proceeds from issuance of common stock

 

 

 

 

 

 

 

 

 

 

 

665,850

 

Dividends paid to non-controlling interest

 

 

 

 

 

 

 

 

(23

)

 

 

 

Net cash used in financing activities

 

 

(4,319

)

 

 

(25,917

)

 

 

(75,032

)

 

 

(79,209

)

Effect of exchange rate changes on cash and cash equivalents and restricted cash

 

 

(355

)

 

 

(2,680

)

 

 

1,129

 

 

 

(1,305

)

Net increase (decrease) in cash and cash equivalents and restricted cash

 

 

36,585

 

 

 

(50,076

)

 

 

32,292

 

 

 

(73,199

)

Cash and cash equivalents and restricted cash at beginning of period

 

 

126,814

 

 

 

199,038

 

 

 

131,107

 

 

 

222,161

 

Cash and cash equivalents and restricted cash at end of period

 

$

163,399

 

 

$

148,962

 

 

$

163,399

 

 

$

148,962

 

 


Non-GAAP Financial Measures

In addition to the measures presented in our condensed consolidated financial statements, we regularly review other measures, defined as non-GAAP financial measures by the SEC, to evaluate our business, measure our performance, identify trends, prepare financial forecasts and make strategic decisions. The key measures we consider are non-GAAP Gross Profit, non-GAAP Gross Margin, non-GAAP Operating Expenses, non-GAAP Operating Income, non-GAAP Operating Margin, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, non-GAAP Profit before Tax, non-GAAP Income Tax Provision (Benefit), non-GAAP Effective Tax Rate, non-GAAP Net Income Attributable to Allegro MicroSystems, Inc, non-GAAP Basic and Diluted Earnings per Share, non-GAAP Free Cash Flow, and non-GAAP Free Cash Flow as a percentage of net sales (collectively, the “Non-GAAP Financial Measures”). These Non-GAAP Financial Measures provide supplemental information regarding our operating performance on a non-GAAP basis that excludes certain gains, losses and charges of a non-cash nature or that occur relatively infrequently and/or that management considers to be unrelated to our core operations, and in the case of non-GAAP Income Tax Provision (Benefit), management believes that this non-GAAP measure of income taxes provides it with the ability to evaluate the non-GAAP Income Tax Provision (Benefit) across different reporting periods on a consistent basis, independent of special items and discrete items, which may vary in size and frequency. These Non-GAAP Financial Measures are used by both management and our board of directors, together with the comparable GAAP information, in evaluating our current performance and planning our future business activities.

The Non-GAAP Financial Measures are supplemental measures of our performance that are neither required by, nor presented in accordance with, GAAP. These Non-GAAP Financial Measures should not be considered as substitutes for GAAP financial measures, such as gross profit, gross margin, net income or any other performance measures derived in accordance with GAAP. Also, in the future we may incur expenses or charges, such as those being adjusted in the calculation of these Non-GAAP Financial Measures. Our presentation of these Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or nonrecurring items. These Non-GAAP Financial Measures exclude costs related to acquisition and related integration expenses, amortization of acquired intangible assets, stock-based compensation, restructuring actions, related-party activities and other non-operational costs.

Non-GAAP Income Tax Provision (Benefit)

In calculating the non-GAAP Income Tax Provision (Benefit), we adjust for the tax effect of adjustments to GAAP results which represents the estimated income tax effect of the adjustments to non-GAAP Profit before Tax described below. We also adjust for any discrete tax items and the impact of non-recurring tax law changes to ensure the non-GAAP Income Tax Rate (“NG ETR”) reflects future operations.

Our fiscal year 2026 and 2027 NG ETR excludes the impact of the 2025 One Big Beautiful Bill Act’s one-time research and development amortization election which accelerates the amortization of previously capitalized domestic research and development over a two-year period. The NG ETR is applied to non-GAAP Profit before Tax to arrive at the tax effect of adjustments to GAAP results.

 

Reconciliation of Non-GAAP Gross Profit and Non-GAAP Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Gross Profit

 

$

107,101

 

 

$

99,292

 

 

$

81,215

 

 

$

297,695

 

 

$

241,648

 

GAAP Gross Margin (% of net sales)

 

 

46.7

%

 

 

46.3

%

 

 

45.7

%

 

 

46.0

%

 

 

45.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

14

 

Purchased intangible amortization

 

 

5,089

 

 

 

5,090

 

 

 

4,875

 

 

 

15,268

 

 

 

14,625

 

Restructuring costs

 

 

659

 

 

 

751

 

 

 

522

 

 

 

2,115

 

 

 

1,738

 

Stock-based compensation

 

 

1,017

 

 

 

1,017

 

 

 

802

 

 

 

2,922

 

 

 

2,180

 

Other Costs

 

 

449

 

 

 

44

 

 

 

 

 

 

493

 

 

 

 

Total Non-GAAP Adjustments

 

$

7,214

 

 

$

6,902

 

 

$

6,204

 

 

$

20,798

 

 

$

18,557

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Gross Profit

 

$

114,315

 

 

$

106,194

 

 

$

87,419

 

 

$

318,493

 

 

$

260,205

 

Non-GAAP Gross Margin (% of net sales)

 

 

49.9

%

 

 

49.6

%

 

 

49.1

%

 

 

49.2

%

 

 

48.9

%

 


 

Reconciliation of Non-GAAP Operating Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Expenses

 

$

97,527

 

 

$

93,049

 

 

$

81,256

 

 

$

284,618

 

 

$

248,252

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and Development Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Research and Development Expenses

 

 

52,878

 

 

 

50,891

 

 

 

43,317

 

 

 

150,269

 

 

 

132,031

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

33

 

 

 

 

 

 

333

 

 

 

33

 

 

 

1,568

 

Purchased intangible amortization

 

 

5

 

 

 

8

 

 

 

 

 

 

16

 

 

 

 

Restructuring costs

 

 

2,663

 

 

 

1,639

 

 

 

568

 

 

 

5,433

 

 

 

997

 

Stock-based compensation

 

 

3,596

 

 

 

4,907

 

 

 

3,960

 

 

 

11,414

 

 

 

11,218

 

Other costs(1)

 

 

196

 

 

 

112

 

 

 

 

 

 

343

 

 

 

3

 

Non-GAAP Research and Development Expenses

 

 

46,385

 

 

 

44,225

 

 

 

38,456

 

 

 

133,030

 

 

 

118,245

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, General and Administrative Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP Selling, General and Administrative Expenses

 

 

44,649

 

 

 

42,158

 

 

 

37,939

 

 

 

134,349

 

 

 

116,221

 

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

3

 

 

 

1

 

 

 

148

 

 

 

134

 

 

 

1,237

 

Purchased intangible amortization

 

 

535

 

 

 

535

 

 

 

535

 

 

 

1,605

 

 

 

1,605

 

Restructuring costs

 

 

2,032

 

 

 

1,158

 

 

 

1,264

 

 

 

4,374

 

 

 

4,355

 

Stock-based compensation

 

 

8,207

 

 

 

7,757

 

 

 

5,826

 

 

 

22,927

 

 

 

18,853

 

Other costs(1)

 

 

1,260

 

 

 

476

 

 

 

391

 

 

 

7,574

 

 

 

(618

)

Non-GAAP Selling, General and Administrative Expenses

 

 

32,612

 

 

 

32,231

 

 

 

29,775

 

 

 

97,735

 

 

 

90,789

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Non-GAAP Adjustments

 

 

18,530

 

 

 

16,593

 

 

 

13,025

 

 

 

53,853

 

 

 

39,218

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Expenses

 

$

78,997

 

 

$

76,456

 

 

$

68,231

 

 

$

230,765

 

 

$

209,034

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 

 

Reconciliation of Non-GAAP Operating Income and Non-GAAP Operating Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Income (Loss)

 

$

9,574

 

 

$

6,243

 

 

$

(41

)

 

$

13,077

 

 

$

(6,604

)

GAAP Operating Margin (% of net sales)

 

 

4.2

%

 

 

2.9

%

 

 

%

 

 

2.0

%

 

 

(1.2

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

36

 

 

 

1

 

 

 

486

 

 

 

167

 

 

 

2,819

 

Purchased intangible amortization

 

 

5,629

 

 

 

5,633

 

 

 

5,410

 

 

 

16,889

 

 

 

16,230

 

Restructuring costs

 

 

5,354

 

 

 

3,548

 

 

 

2,354

 

 

 

11,922

 

 

 

7,090

 

Stock-based compensation

 

 

12,820

 

 

 

13,681

 

 

 

10,588

 

 

 

37,263

 

 

 

32,251

 

Other costs(1)

 

 

1,905

 

 

 

632

 

 

 

391

 

 

 

8,410

 

 

 

(615

)

Total Non-GAAP Adjustments

 

$

25,744

 

 

$

23,495

 

 

$

19,229

 

 

$

74,651

 

 

$

57,775

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Operating Income

 

$

35,318

 

 

$

29,738

 

 

$

19,188

 

 

$

87,728

 

 

$

51,171

 

Non-GAAP Operating Margin (% of net sales)

 

 

15.4

%

 

 

13.9

%

 

 

10.8

%

 

 

13.6

%

 

 

9.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions.

 

 


Reconciliation of EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Net Income (Loss)

 

$

8,362

 

 

$

6,583

 

 

$

(6,799

)

 

$

1,783

 

 

$

(58,025

)

GAAP Net Income (Loss) Margin (% of net sales)

 

 

3.6

%

 

 

3.1

%

 

 

(3.8

)%

 

 

0.3

%

 

 

(10.9

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

4,910

 

 

 

5,730

 

 

 

7,762

 

 

 

16,999

 

 

 

23,492

 

Interest income

 

 

(114

)

 

 

(159

)

 

 

(388

)

 

 

(507

)

 

 

(1,302

)

Income tax benefit

 

 

(7,868

)

 

 

(9,298

)

 

 

(803

)

 

 

(13,997

)

 

 

(9,233

)

Depreciation & amortization

 

 

17,001

 

 

 

16,611

 

 

 

16,123

 

 

 

49,828

 

 

 

48,578

 

EBITDA

 

$

22,291

 

 

$

19,467

 

 

$

15,895

 

 

$

54,106

 

 

$

3,510

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

36

 

 

 

1

 

 

 

486

 

 

 

167

 

 

 

5,623

 

Restructuring costs

 

 

5,000

 

 

 

3,403

 

 

 

2,354

 

 

 

11,227

 

 

 

6,835

 

Stock-based compensation

 

 

12,820

 

 

 

13,681

 

 

 

10,588

 

 

 

37,263

 

 

 

32,251

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

 

 

 

34,752

 

Other costs(1)

 

 

6,037

 

 

 

4,271

 

 

 

998

 

 

 

17,612

 

 

 

1,610

 

Adjusted EBITDA

 

$

46,184

 

 

$

40,823

 

 

$

30,321

 

 

$

120,375

 

 

$

84,581

 

Adjusted EBITDA Margin (% of net sales)

 

 

20.1

%

 

 

19.0

%

 

 

17.0

%

 

 

18.6

%

 

 

15.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Profit before Tax

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Income (Loss) before Income Taxes

 

$

494

 

 

$

(2,715

)

 

$

(7,602

)

 

$

(12,214

)

 

$

(67,258

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

36

 

 

 

1

 

 

 

486

 

 

 

167

 

 

 

5,623

 

Transaction-related interest

 

 

225

 

 

 

645

 

 

 

192

 

 

 

1,730

 

 

 

1,042

 

Purchased intangible amortization

 

 

5,629

 

 

 

5,633

 

 

 

5,410

 

 

 

16,889

 

 

 

16,230

 

Restructuring costs

 

 

5,354

 

 

 

3,736

 

 

 

2,354

 

 

 

12,110

 

 

 

6,835

 

Stock-based compensation

 

 

12,820

 

 

 

13,681

 

 

 

10,588

 

 

 

37,263

 

 

 

32,251

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

 

 

 

34,752

 

Other costs(1)

 

 

6,422

 

 

 

4,271

 

 

 

1,427

 

 

 

17,997

 

 

 

5,662

 

Total Non-GAAP Adjustments

 

$

30,486

 

 

$

27,967

 

 

$

20,457

 

 

$

86,156

 

 

$

102,395

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Profit before Tax

 

$

30,980

 

 

$

25,252

 

 

$

12,855

 

 

$

73,942

 

 

$

35,137

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure such as project evaluation costs, which consist of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions and income (loss) in earnings of equity investments.

 

 

 

Reconciliation of Non-GAAP Income Tax Provision (Benefit) and Non-GAAP Effective Tax Rate

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Income Tax Benefit

 

$

(7,868

)

 

$

(9,298

)

 

$

(803

)

 

$

(13,997

)

 

$

(9,233

)

GAAP effective tax rate

 

 

(1,592.7

)%

 

 

342.5

%

 

 

10.6

%

 

 

114.6

%

 

 

13.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax effect of adjustments to GAAP results

 

 

10,002

 

 

 

10,733

 

 

 

398

 

 

 

19,252

 

 

 

10,074

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP Income Tax Provision (Benefit)

 

$

2,134

 

 

$

1,435

 

 

$

(405

)

 

$

5,255

 

 

$

841

 

Non-GAAP effective tax rate

 

 

6.9

%

 

 

5.7

%

 

 

(3.2

)%

 

 

7.1

%

 

 

2.4

%

 


 

 

Reconciliation of Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc. and Non-GAAP Earnings per Share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Net Income (Loss) Attributable to Allegro MicroSystems, Inc.(1)

 

$

8,299

 

 

$

6,519

 

 

$

(6,860

)

 

$

1,591

 

 

$

(58,210

)

GAAP Basic weighted average common shares

 

 

185,172,199

 

 

 

185,074,119

 

 

 

184,011,189

 

 

 

184,944,427

 

 

 

188,886,583

 

GAAP Diluted weighted average common shares

 

 

186,208,258

 

 

 

186,305,785

 

 

 

184,011,189

 

 

 

185,998,601

 

 

 

188,886,583

 

GAAP Basic Income (Loss) per Share

 

$

0.04

 

 

$

0.04

 

 

$

(0.04

)

 

$

0.01

 

 

$

(0.31

)

GAAP Diluted Income (Loss) per Share

 

$

0.04

 

 

$

0.03

 

 

$

(0.04

)

 

$

0.01

 

 

$

(0.31

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Transaction-related costs

 

 

36

 

 

 

1

 

 

 

486

 

 

 

167

 

 

 

5,623

 

Transaction-related interest

 

 

225

 

 

 

645

 

 

 

192

 

 

 

1,730

 

 

 

1,042

 

Purchased intangible amortization

 

 

5,629

 

 

 

5,633

 

 

 

5,410

 

 

 

16,889

 

 

 

16,230

 

Restructuring costs

 

 

5,354

 

 

 

3,736

 

 

 

2,354

 

 

 

12,110

 

 

 

6,835

 

Stock-based compensation

 

 

12,820

 

 

 

13,681

 

 

 

10,588

 

 

 

37,263

 

 

 

32,251

 

Loss on change in fair value of forward repurchase contract

 

 

 

 

 

 

 

 

 

 

 

 

 

 

34,752

 

Other costs(2)

 

 

6,422

 

 

 

4,271

 

 

 

1,427

 

 

 

17,997

 

 

 

5,662

 

Total Non-GAAP Adjustments

 

 

30,486

 

 

 

27,967

 

 

 

20,457

 

 

 

86,156

 

 

 

102,395

 

Tax effect of adjustments to GAAP results(3)

 

 

(10,002

)

 

 

(10,733

)

 

 

(398

)

 

 

(19,252

)

 

 

(10,074

)

Non-GAAP Net Income Attributable to Allegro MicroSystems, Inc.

 

$

28,783

 

 

$

23,753

 

 

$

13,199

 

 

$

68,495

 

 

$

34,111

 

Basic weighted average common shares

 

 

185,172,199

 

 

 

185,074,119

 

 

 

184,011,189

 

 

 

184,944,427

 

 

 

188,886,583

 

Diluted weighted average common shares

 

 

186,208,258

 

 

 

186,305,785

 

 

 

184,485,792

 

 

 

185,998,601

 

 

 

189,577,693

 

Non-GAAP Basic Earnings per Share

 

$

0.16

 

 

$

0.13

 

 

$

0.07

 

 

$

0.37

 

 

$

0.18

 

Non-GAAP Diluted Earnings per Share

 

$

0.15

 

 

$

0.13

 

 

$

0.07

 

 

$

0.37

 

 

$

0.18

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) GAAP Net Income (Loss) Attributable to Allegro MicroSystems, Inc. represents GAAP Net Income (Loss) adjusted for Net Income Attributable to non-controlling interests.

 

(2) Included in non-GAAP other costs are non-recurring charges that are individually immaterial for separate disclosure, such as project evaluation costs, which consists of costs and estimated costs incurred in connection with debt and equity financings or other non-recurring transactions, income (loss) in earnings of equity investments, and unrealized losses (gains) on investments.

 

(3) To calculate the tax effect of adjustments to GAAP results, the Company considers each Non-GAAP adjustment by tax jurisdiction, reverses all discrete items, non-recurring law changes to calculate an annual NG ETR. This NG ETR is then applied to Non-GAAP Profit Before Tax to arrive at the tax effect of adjustments to GAAP results.

 

 


 

Reconciliation of Non-GAAP Free Cash Flow and Non-GAAP Free Cash Flow as Percentage of Net Sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three-Month Period Ended

 

 

Nine-Month Period Ended

 

 

December 26, 2025

 

 

September 26, 2025

 

 

December 27, 2024

 

 

December 26, 2025

 

 

December 27, 2024

 

 

(Dollars in thousands)

 

 

(Dollars in thousands)

 

GAAP Operating Cash Flow

 

$

45,375

 

 

$

20,362

 

 

$

(8,183

)

 

$

127,355

 

 

$

41,560

 

GAAP Operating Cash Flow (% of net sales)

 

 

19.8

%

 

 

9.5

%

 

 

(4.6

)%

 

 

19.7

%

 

 

7.8

%

Non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property, plant and equipment

 

 

(4,116

)

 

 

(6,444

)

 

 

(13,615

)

 

 

(21,160

)

 

 

(34,564

)

Non-GAAP Free Cash Flow

 

$

41,259

 

 

$

13,918

 

 

$

(21,798

)

 

$

106,195

 

 

$

6,996

 

Non-GAAP Free Cash Flow (% of net sales)

 

 

18.0

%

 

 

6.5

%

 

 

(12.3

)%

 

 

16.4

%

 

 

1.3

%

Investor Contact:

Jalene Hoover

VP of Investor Relations & Corporate Communications

+1 (512) 751-6526

jhoover@allegromicro.com